Navigation Links
Study: Smoking Increases HPV Risks; polyDNA Recommends Gene-Eden-VIR Against HPV
Date:3/17/2013

Rochester, NY (PRWEB) March 17, 2013

"Smokers have an increased risk of developing precancerous and cancerous cervical lesions caused by infection with high-risk HPV types."(Sexually Transmitted Diseases) [1]

The same study suggested that the risk of developing genital warts is not as readily apparent if one happens to be a smoker. The authors wrote that, "Some studies report no significant association between smoking and acquisition of genital warts among women, whereas others report an increased risk of genital warts among female smokers, ranging up to a fivefold increased risk for current smokers compared with non-smokers."

polyDNA would like to point out that there is no doubt that smoking lowers the immune system and thus increases smoker's risk for developing cervical or other cancers. As the authors of the study noted, "Smoking may influence the susceptibility to genital warts through a causal immunosuppressive effect, and/or through an association with risk taking that extends to sexual behavior."

What does this mean for the average person?

polyDNA believes studies, like the one quoted above, show that both women and men should stop smoking in order to decrease damage to the immune system. A healthy immune system is the best means of combating an HPV infection. In fact, the CDC says "In 90% of cases, the body's immune system clears HPV naturally within two years."

The problem arises when the immune system is weakened and the HPV virus is able to cause symptoms like genital warts.

HPV is the most common sexually transmitted infection. In fact, over 20 million people in the U.S. are infected with the Human Papillomavirus. Since HPV is transmitted through any skin-to-skin contact, one does not have to have sex in order to become infected with the virus.

Mike Davis from polyDNA noted that this is why many young people call HPV, "stuff that gets up around the sides of condoms."

Individuals can, however, go for life without symptoms ... and they can help prevent spreading the diseases these viruses cause.

How does one do it?

polyDNA stresses that it is done by lowering the load of latent viruses within the body. When the number of viruses in the body is lowered to the point that a person might as well not have them at all ... that person can remain symptom free.

"The key to your health is to reduce the level of the latent viruses in your body to harmless levels." - Dr. Hanan Polansky

Gene-Eden-VIR is the only scientifically based, all natural, herbal supplement with scientific studies published in the U.S. National Library of Medicine and National Institutes of Health. It has been specifically designed and formulated to boost the body's own immune system in order to counter many of the latent viruses of today, including the Genital Warts virus.

The truth is Gene-Eden-VIR is extremely efficient against the latent version of the virus that causes genital warts; each ingredient was chosen through a scientific approach. polyDNA scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world in order to identify the safest, most effective natural ingredients that target the latent (dormant) HPV Virus.

Gene-Eden-VIR is totally safe, and in a post marketing study, there were no reports of side effects. Each capsule contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified.

People can easily access these scientific papers on the ingredients of Gene-Eden-VIR on pubmed.gov.

Gene-Eden-VIR is sold online through the Gene-Eden website. Each bottle of Gene-Eden-VIR (a one month's supply) costs just $37.99.

Ordering Gene-Eden-VIR is completely secure and confidential. Visit and learn how to order Gene-Eden-VIR.

To learn more about Gene-Eden-VIR, the only product on the market today that helps the immune system kill the latent Human Papillomavirus (HPV), and that is scientifically backed by published material, visit the Gene-Eden-VIR website, or call our American line at: 585-250-9999.

Reference

[1] Rajkumar T, Appleby P, Beral V, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies - international collaboration of epidemiological studies of cervical cancer. Int J Cancer 2006;118:1481 - 95

###

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA.

The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases. polyDNA developed Gene-Eden-VIR (http://www.buy-gene-eden.com), an antiviral natural remedy that helps the immune system kill latent viruses.

.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10535309.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Omega XL Reports New Independent Study: Omega-3s Can Boost Children’s IQ
2. Study: 15% of Children Ages 10 - 14 Consider Using Steroids; polyDNA Recommends Muxscle for Safe Muscle Building
3. Study: Dynamic new software improves care of aging brain
4. Bel Marra Health Reports on a New Study: Female Obesity Could Be Due to Less Participation in Household Tasks
5. Study: Steroid Abuse in Teens is Increasing; polyDNA Recommends Muxscle for Safe Muscle Building
6. Study: Catheter-based varicose vein treatments more cost-effective
7. Penn study: Financial incentives affect prostate cancer treatment patterns
8. Study: Mega Vitamins Wont Help After Heart Attack, Chelation Treatment Might
9. Study: Diabetic medication may protect patients from developing heart failure
10. Doctors Health Press Reports on German Study: Only 20% of Patients Get Colonoscopies, Important in Preventing and Diagnosing Colon Cancer
11. Bel Marra Health Reports on a New Study: Parents are Much More Likely to Experience Symptoms of Depression and Anxiety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology: